The need for new therapeutic approaches in visceral leishmaniasis during HIV infection.
Lafeuillade
A
A
Quilichini
R
R
Dhiver
C
C
Mary
C
C
Gastaut
J A
JA
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D004359:Drug Therapy, Combination; D015497:HIV-1; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008297:Male; D008536:Meglumine / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000188:drug therapy*
D008536:Meglumine; D007371:Interferon-gamma